Scarica l'app Stockscreener
1.69
51.57%
0.575
Dopo l'orario di chiusura:
1.64
-0.05
-2.96%
Precedente Chiudi:
$1.115
Aprire:
$2.1
Volume 24 ore:
152.87M
Relative Volume:
35.79
Capitalizzazione di mercato:
$8.04M
Reddito:
$1.52M
Utile/perdita netta:
$-13.97M
Rapporto P/E:
-0.5541
EPS:
-3.05
Flusso di cassa netto:
$-13.29M
1 W Prestazione:
+46.96%
1M Prestazione:
+28.03%
6M Prestazione:
+113.92%
1 anno Prestazione:
-35.25%
Intervallo 1D:
$1.51
$2.60
Intervallo di 1 settimana:
$1.05
$2.60
Portata 52W:
$0.55
$3.06
Predictive Oncology Inc Stock (POAI) Company Profile
Nome
Predictive Oncology Inc
Settore
Industria
Telefono
412-432-1500
Indirizzo
91 43RD STREET, PITTSBURGH, MN
Confronta POAI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
1.69 | 8.04M | 1.52M | -13.97M | -13.29M | -3.05 |
|
ISRG
Intuitive Surgical Inc
|
519.81 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.08 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.80 | 45.90B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
221.29 | 32.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
225.80 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Iniziato | H.C. Wainwright | Buy |
Predictive Oncology Inc Borsa (POAI) Ultime notizie
Predictive Oncology developed predictive models from 21 compounds from NPDC - TipRanks
Predictive Oncology (POAI) Stock Surges Following Major Drug Discovery Breakthrough - Stocks Telegraph
Predictive Oncology Develops Advanced Predictive Models for Natural Compounds in Cancer Drug Discovery - Nasdaq
Predictive Oncology Successfully Develops Predictive Models - GlobeNewswire
Revolutionary AI Platform Discovers Superior Cancer Treatments in Record Time - StockTitan
Milestone Merger Payment with Predictive Oncology to Advance AI - newschannelnebraska.com
Predictive Oncology Sells Skyline Medical Assets To DeRoyal Industries - Nasdaq
Predictive Oncology Sells Skyline Medical Assets to DeRoyal Industries - citybiz
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries to Focus on AI-Driven Drug Discovery - Nasdaq
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewswire
Strategic Pivot: Predictive Oncology Divests Medical Assets for AI-Powered Future - StockTitan
Predictive Oncology (POAI) Expected to Announce Earnings on Thursday - Defense World
Predictive Oncology to launch ChemoFx assay in Europe - MSN
Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Insider Monkey
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals
MarketsMedicine Hat News - Financial Content
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail
Milestone Merger Payment made with Predictive Oncology - openPR
Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire
Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times
Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq
Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan
Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan
Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Down 26.1% in February - Defense World
Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow
Predictive Oncology announces registered direct offering; shares fall - MSN
Predictive Oncology Inc. Completes Registered Direct Offering of 363,336 Shares at $1.50 Per Share - Nasdaq
Predictive Oncology Closes Registered Direct Offering - The Bakersfield Californian
Can This $545K Capital Raise Give Predictive Oncology The Runway It Needs? - StockTitan
SEC Form 424B5 filed by Predictive Oncology Inc. - Quantisnow
Predictive Oncology prices 363,336 shares at $1.50 in registered direct offering - TipRanks
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
Inside Predictive Oncology's Latest Capital Raise: Key Details of the $545K Direct Offering - StockTitan
Predictive Oncology (NASDAQ:POAI) and Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) Financial Review - Defense World
Predictive Oncology (POAI) Struggles AI-Driven Drug Repurposing Breakthrough - Insider Monkey
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing - GlobeNewswire
What's Going On With Predictive Oncology Shares Tuesday?Predictive Oncology (NASDAQ:POAI) - Benzinga
Predictive Oncology reports positive results using AI for drug repurposing - TipRanks
Predictive Oncology Leverages AI To Identify Repurposed Drugs For Cancer Treatment Advancement - Nasdaq
AI Drug Discovery Milestone: Predictive Oncology Finds Cancer Treatment Gold in Abandoned Drugs - StockTitan
Predictive Oncology (NASDAQ:POAI) Stock Quotes, Forecast and News Summary - Benzinga
Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform - Business Wire
AI in Oncology Market worth $11.52 billion by 2030 - WICZ
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis - The Manila Times
Predictive Oncology Partners with Switzerland-Based Tecan - GlobeNewswire
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput - The Bakersfield Californian
Predictive Oncology's Game-Breaking Cancer Research Platform Unlocks $69.5B Market Potential - StockTitan
Certis Oncology Solutions President & CEO, Peter Ellman, Presents at the 24 - Business Wire
Predictive Oncology Inc Azioni (POAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):